Clinical trial

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

NCT02252978

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2016-07-01

PhasePHASE2

Study timeline

Study start (actual)2016-07-01Date precision: month

Registry last updated2018-07-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

ciprofloxacinDRUG · verified · RxNorm: ciprofloxacin

quality-of-life assessmentOTHER

laboratory biomarker analysisOTHER

Sponsors & collaborators

Wake Forest University Health Scienceslead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02252978 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.